During the departed week, outstanding advancements and improvements in various clinical disciplines filled the media. What’s …

The Chinese National Medical Products Administration (NMPA) has approved Gilead’s (GILD) HIV combination product Descovy®.  In China, Descovy is …

The Week in Review #35 Politics and the Market The market tumbled today as Theresa May, …

Today, the market took another beating as a result of either an intentional or an unintentional …

Another reason was found to hit the market when the economy is good and sustained and …

Prohost Letter #425 When Common Sense Fails to Explain the Market Performance It is not unusual …

Vertex Pharmaceuticals’ triple combination, which added the corrector VX-659 to the tezacaftor and ivacaftor combination, resulted …

We hope you all took advantage of the Thanksgiving holiday to rest and relax. We did. …

Aimmune Therapeutics (AIMT) has news. A lot of it is from a successful phase 3 trial …

The Week in Review, which we will post soon, is going to provide news that cancer …